Your Client Rank:
Loading...
99
Updated 17-Sep-2021
| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Eisai | 11.3% | 1.1% | -3.4% | -6.6% | 19.1% | 1.6% | 31.9% | 31.9% |
| Biogen | 10.8% | 0.4% | -7.2% | -7.9% | 6.4% | 1.2% | 12.1% | 15.0% |
| Astra | 10.7% | 1.9% | -4.1% | -2.5% | 10.7% | 2.1% | 20.1% | 17.5% |
| Lilly | 10.7% | 0.6% | -4.4% | -5.8% | 7.1% | 4.3% | 17.9% | 19.1% |
| Daiichi | 9.7% | 2.4% | -0.9% | -4.8% | 24.9% | -0.4% | 36.3% | 36.3% |
| Novo | 8.9% | 0.3% | -1.7% | 0.4% | 1.4% | 0.4% | 10.2% | 12.0% |
| Vertex | 7.9% | 0.2% | 0.0% | -11.0% | 6.8% | 0.6% | 9.5% | 9.2% |
| Shionogi | 6.6% | 0.0% | -3.6% | -4.6% | 4.4% | 15.9% | 5.9% | 6.6% |
| Lundbeck | 6.1% | 0.8% | -3.2% | -4.3% | 16.7% | -0.6% | 18.3% | 18.3% |
| Astellas | 5.9% | -0.2% | -3.5% | -0.2% | 6.8% | 2.9% | 12.2% | 17.6% |
| Merck | 5.8% | 1.1% | -3.1% | -2.0% | 5.2% | 1.0% | 11.5% | 12.7% |
| Glaxo | 5.0% | 0.5% | -2.1% | -0.8% | 4.1% | 3.2% | 9.5% | 9.0% |
| Roche | 4.3% | 0.6% | -0.4% | -0.6% | 1.8% | 0.6% | 6.3% | 6.4% |
| Sanofi | 4.3% | 0.7% | -4.1% | -3.0% | 5.9% | 0.0% | 8.6% | 8.8% |
| Chugai | 3.0% | 0.7% | -0.3% | 1.4% | 0.7% | -1.5% | 4.2% | 4.4% |
| Amgen | 3.0% | 0.0% | -1.1% | -0.1% | 0.6% | 2.4% | 5.2% | 7.2% |
| Novartis | 2.7% | 0.3% | -1.1% | -0.5% | 1.9% | 0.2% | 5.6% | 6.0% |
| JnJ | 2.5% | 0.2% | -2.8% | -1.5% | 2.4% | 0.5% | 4.9% | 5.7% |
| Bristol | 2.3% | -0.9% | -1.5% | -1.0% | -0.3% | 0.2% | 2.3% | 2.9% |
| Bayer | 1.6% | 1.3% | 0.1% | -0.7% | 4.2% | -12.5% | 4.5% | 4.5% |
| Teva | 0.9% | 0.6% | -0.2% | -0.9% | 1.9% | 0.6% | 4.7% | 4.3% |
| AbbVie | 0.9% | -0.6% | -0.2% | 1.6% | -0.9% | 1.8% | 0.6% | 1.1% |
| Gilead | 0.5% | -0.1% | 0.6% | 0.8% | -0.7% | 0.2% | 0.5% | 1.5% |
| Viatris | 0.5% | 0.5% | -2.0% | 1.3% | 1.6% | 0.9% | 3.3% | 2.3% |
| Takeda | 0.1% | 0.2% | -0.8% | 0.8% | 6.0% | -7.7% | 13.3% | 13.3% |
| Regeneron | -2.4% | -0.1% | 3.9% | 3.2% | -3.2% | 5.0% | -6.6% | -7.1% |
| Pfizer | -8.4% | 7.6% | 9.6% | 9.7% | 5.2% | -0.6% | -3.2% | -2.6% |
| EU Major | 4.9% | 0.9% | -1.8% | -1.0% | 4.2% | 1.0% | 8.7% | 8.1% |
| Other EU | 6.1% | 0.8% | -3.2% | -4.3% | 16.7% | -0.6% | 18.3% | 18.3% |
| US Major | 1.2% | 1.5% | -0.2% | 0.8% | 2.7% | 0.8% | 4.1% | 7.0% |
| US Big Biotech | 3.1% | 0.0% | -0.9% | -2.1% | 0.9% | 1.6% | 3.0% | 2.3% |
| Other US | 0.7% | 0.5% | -1.2% | 0.0% | 1.7% | 0.8% | 3.9% | 3.1% |
| Japanese | 4.3% | 0.7% | -1.2% | -1.0% | 7.3% | -1.3% | 13.5% | 16.2% |
